Navigation Links
RHEI Pharmaceticals to Present at Rodman & Renshaw Conference
Date:11/2/2007

NEW HAVEN, Conn., Nov. 2 /PRNewswire/ -- RHEI Pharmaceuticals, Inc., a fully integrated specialty pharmaceuticals company focused on bringing proprietary medicines to the China market, will be presenting, at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Monday, November 5, 2007 at 2:20 p.m., eastern.

RHEI Pharmaceuticals provides a matchless turnkey solution for any company wishing to gain access to the fastest growing market in the world. The company is actively seeking both new investors and new products for the China market.

RHEI in-licenses proprietary pharmaceuticals for the China market and utilizes its network of experienced clinicians to achieve expedited market approval and commercialization. RHEI is unique in having successfully integrated a full pharmaceutical operation in China and in its acquisition of approved and late-stage western pharmaceuticals that address the special needs of the China healthcare market. RHEI's nationwide salesforce in China, led by Big Pharma experienced sales and marketing executives, applies western pharmaceutical marketing practices focusing on key opinion leaders (KOLs) within the major hospitals throughout China.

RHEI will be represented at the Rodman & Renshaw conference by its Chairman, Harry H. Penner, Jr., and its VP Commercial Operations, Scott Kozak.

About RHEI Pharmaceuticals

RHEI Pharmaceuticals is a venture backed specialty pharmaceuticals company with operations in the U.S. and in China that acquires, licenses, develops and commercializes in China proprietary drug therapies based upon the unmet needs of the emerging China pharmaceuticals market. RHEI specializes in hospital- based proprietary products with a therapeutic focus on urgent unmet needs in the areas of cancer, cardiovascular disease, neurology, anti-infectives, and other life threatening conditions.


'/>"/>
SOURCE RHEI Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... discovery that turns 160 years of neuroanatomy on its ... to be essential for the fast transmission of impulses ... ubiquitous as thought, according to a new work lead ... Institute (HSCI) and the University,s Department of Stem Cell ... of Harvard,s Department of Molecular and Cellular Biology. , ...
(Date:4/18/2014)... Two Simon Fraser University psychologists have made a ... treatment of attention-deficit disorders. , This discovery opens ... may hinder or suppress a specific brain activity ... prevent distraction. , The Journal of Neuroscience ... discovery by John McDonald, an associate professor of ...
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Scientists discover brain's anti-distraction system 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2
... Cheresh, PhD, professor of pathology at the University of ... for translational research at the Moores UCSD Cancer Center, ... Award, the highest prize bestowed by the Metastasis Research ... involving metastasis. Cheresh was honored at a recent ...
... study published in the Journal of Sexual Medicine ... experience sexual problems after breast cancer. The results showed ... approximately two years post diagnosis. Mary Panjari, PhD, of ... the sexual well-being nearly two years after diagnosis and ...
... into the hearts of patients who have severe aortic stenosis ... has been found to both save lives and improve the ... to be published online at 2 p.m. Pacific time today ... The study will also be presented at 8 a.m. Pacific ...
... By Serena Gordon HealthDay Reporter , ... and Drug Administration on Wednesday approved the first oral ... system disorder that has traditionally been treated with injectable ... and delay the progression of debilitating symptoms in patients ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... sick to withstand surgery to treat a narrowed aortic valve, ... alive, researchers say. As many as 300,000 Americans suffer ... valve from fully opening and sending blood back into the ...
... 21, 2010 Chicago The prevalence of periodontal ... than originally estimated. Research published in the Journal ... Control and Prevention (CDC) and the American Academy of ... may have been underestimated by as much as 50 ...
Cached Medicine News:Health News:David Cheresh receives top award for cancer metastasis research 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 2Health News:New treatment for severe aortic stenosis shown to save lives, Stanford researchers say 3Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 2Health News:FDA Approves 1st Oral Drug to Reduce MS Relapses 3Health News:New Procedure for Aortic Valve Replacement Looks Promising 2Health News:New Procedure for Aortic Valve Replacement Looks Promising 3Health News:Gum disease found to be significant public health concern 2
(Date:1/14/2014)... 14, 2014 The Brandeis Medical Center, led by Dr. ... premier and affordable laser tattoo removal experience with the advanced Astanza ... in providing high quality cosmetic services with cutting edge medical technology ... Southern California has seen a dramatic increase in ...
(Date:1/14/2014)... Animal Emergency Critical Care, a LifeCentre partner practice, located at ... is the first in Loudoun County to ... Susan M. Barnes , Medical Director, is a well-seasoned veterinarian ... Cole Taylor , are avid scuba divers. "As altitude skiers and ...
(Date:1/14/2014)... 2014   Oligomerix, Inc. , a privately held company ... disease (AD) and related neurodegenerative disorders, announced today the ... NY as of January 15, 2014 and ... York Medical College. Oligomerix, which is focused ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... ANTONIO, Feb. 28, 2011 Advanced Cell Diagnostics, ... clinical study utilizing RNAscope™ technology to detect human ... of head and neck cancer. HPV status determined ... of patient outcome and highly concordant with that ...
... 2011 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... dividend policy for 2011 and beyond and declared that the four ... be $0.15 per share of common stock.  The $0.15 dividends will ... 15 to all stockholders who own shares of PDL on March ...
Cached Medicine Technology:ACD Announces Clinical Study Results Using its RNAscope™ Technology 2ACD Announces Clinical Study Results Using its RNAscope™ Technology 3PDL BioPharma Announces Regular Quarterly Dividend Policy 2
... Density, multi-frequency, linear flexible laparoscopic ... the UST-5536, this "Omni-Plane transducer ... horizontally as well as pivots ... that target lesions can be ...
Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....
This is a 3D transducer for endovaginal imaging in OB/GYN....
This is a 3D transducer for endovaginal imaging in OB/GYN....
Medicine Products: